Published in J Virol on April 30, 2008
Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther (2011) 1.42
Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol (2011) 1.28
Adenovirus. Curr Top Microbiol Immunol (2010) 1.27
Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol (2009) 1.27
Insights into adenovirus host cell interactions from structural studies. Virology (2008) 1.25
AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc Natl Acad Sci U S A (2012) 1.22
Regulation of virus neutralization and the persistent fraction by TRIM21. J Virol (2012) 1.13
Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol (2010) 1.12
Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev Vaccines (2009) 1.08
Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology (2011) 0.98
Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm. Front Immunol (2011) 0.90
TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus. PLoS Pathog (2015) 0.88
TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity. Immunol Rev (2015) 0.81
Adenovirus-triggered innate signalling pathways. Eur J Microbiol Immunol (Bp) (2011) 0.79
Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus. PLoS One (2014) 0.78
Emerging roles for ubiquitin in adenovirus cell entry. Biol Cell (2012) 0.77
Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein. J Virol (2012) 0.77
Directed evolution of mutator adenoviruses resistant to antibody neutralization. J Virol (2013) 0.76
Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway. J Gen Virol (2016) 0.75
Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells. PLoS Pathog (2016) 0.75
Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative. Antiviral Res (2014) 0.75
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell (1993) 13.21
Cytoarchitecture and physical properties of cytoplasm: volume, viscosity, diffusion, intracellular surface area. Int Rev Cytol (2000) 6.61
Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 6.34
Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol (1999) 4.00
Sequence and characterization of cytoplasmic nuclear protein import factor p97. J Cell Biol (1995) 3.85
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol (2005) 3.04
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol (2005) 2.84
Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol (2001) 2.72
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J Virol (1988) 2.61
A superhighway to virus infection. Cell (2006) 2.58
Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis (2007) 2.56
Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe (2008) 2.26
The impact of adenovirus infection on the immunocompromised host. Rev Med Virol (2003) 2.07
Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J (2001) 1.98
Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther (2000) 1.97
Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol (2006) 1.96
The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol (2000) 1.95
Intact microtubules support adenovirus and herpes simplex virus infections. J Virol (2002) 1.84
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J (1997) 1.82
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77
Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol (1998) 1.75
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63
Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J Gen Virol (1992) 1.57
Adenovirus receptors. J Virol (2005) 1.55
Adenovirus binds to rat brain microtubules in vitro. J Virol (1975) 1.49
Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis (2002) 1.45
Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43
Postentry neutralization of adenovirus type 5 by an antihexon antibody. J Virol (2004) 1.40
Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J (2003) 1.38
Nuclear import of adenovirus DNA in vitro involves the nuclear protein import pathway and hsc70. J Biol Chem (2000) 1.36
Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol (2004) 1.36
Neutralization of animal virus infectivity by antibody. Arch Virol (2007) 1.34
Binding of adenovirus to microtubules. II. Depletion of high-molecular-weight microtubule-associated protein content reduces specificity of in vitro binding. J Virol (1977) 1.18
Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol Biol Cell (2005) 1.16
Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera. J Virol (1985) 1.12
Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol (2006) 1.02
Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber. Virology (1995) 1.01
Proline 137 is critical for adenovirus protease encapsidation and activation but not enzyme activity. Virology (1995) 1.01
Use of chimeric adenoviral vectors to assess capsid neutralization determinants. Virology (2005) 0.96
Association of adenovirus with the microtubule organizing center. J Virol (2003) 0.95
PU.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection. J Immunol (2007) 0.91
Antibody-triggered dissociation of adenovirus penton capsomer. Virology (1981) 0.90
Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer. Viral Immunol (2000) 0.89
Nuclear import in viral infections. Curr Top Microbiol Immunol (2005) 0.88
Phage display. Immunotechnology (1995) 0.87
Inhibition of cell adhesion to the virus by synthetic peptides of fiber knob of human adenovirus serotypes 2 and 3 and virus neutralisation by anti-peptide antibodies. Virus Res (1996) 0.84
Antibody-mediated uncoating of adenovirus in vitro. FEMS Microbiol Lett (1992) 0.83
Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science (2003) 3.64
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology (2009) 3.35
Differential regulation of cell motility and invasion by FAK. J Cell Biol (2003) 3.15
Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol (2005) 3.04
Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe (2008) 2.26
Crystal structure of human adenovirus at 3.5 A resolution. Science (2010) 2.17
Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol (2006) 1.96
Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol (2007) 1.91
Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther (2003) 1.85
Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol (2002) 1.79
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77
Nucleocytoplasmic transport: navigating the channel. Traffic (2003) 1.66
Energy- and temperature-dependent transport of integral proteins to the inner nuclear membrane via the nuclear pore. J Cell Biol (2004) 1.58
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120. Virology (2008) 1.56
Characterization of resistance mutations against HCV ketoamide protease inhibitors. Antiviral Res (2007) 1.55
The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther (2005) 1.54
Flexibility of the adenovirus fiber is required for efficient receptor interaction. J Virol (2003) 1.49
Beta1 integrin mediates internalization of mammalian reovirus. J Virol (2006) 1.43
Importin beta contains a COOH-terminal nucleoporin binding region important for nuclear transport. J Cell Biol (2003) 1.43
Molecular basis for the recognition of a nonclassical nuclear localization signal by importin beta. Mol Cell (2002) 1.42
Postentry neutralization of adenovirus type 5 by an antihexon antibody. J Virol (2004) 1.40
Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J (2003) 1.38
CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. J Mol Biol (2005) 1.35
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Influence of cargo size on Ran and energy requirements for nuclear protein import. J Cell Biol (2002) 1.30
Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol (2011) 1.28
Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol Cell Proteomics (2011) 1.28
Adenovirus. Curr Top Microbiol Immunol (2010) 1.27
Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol (2006) 1.27
Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol (2009) 1.27
Nuclear envelope transmembrane proteins (NETs) that are up-regulated during myogenesis. BMC Cell Biol (2006) 1.26
The nuclear membrane proteome: extending the envelope. Trends Biochem Sci (2005) 1.25
Sumoylation regulates nuclear localization of lipin-1alpha in neuronal cells. PLoS One (2009) 1.20
Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signal-regulated kinase signaling in myoblast differentiation. Mol Cell Biol (2009) 1.19
Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am J Respir Cell Mol Biol (2003) 1.18
Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol (2010) 1.12
Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes. Protein Sci (2008) 1.12
Regulation of myoblast differentiation by the nuclear envelope protein NET39. Mol Cell Biol (2009) 1.11
Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol (2011) 1.09
Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5. Virology (2010) 1.08
Virus yoga: the role of flexibility in virus host cell recognition. Trends Microbiol (2004) 1.08
Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J Virol (2009) 1.08
Identification of HCV protease inhibitor resistance mutations by selection pressure-based method. Nucleic Acids Res (2009) 1.07
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034). Antimicrob Agents Chemother (2008) 1.04
Integrin and defensin modulate the mechanical properties of adenovirus. J Virol (2012) 1.04
The stability of the nuclear lamina polymer changes with the composition of lamin subtypes according to their individual binding strengths. J Biol Chem (2004) 1.03
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG. Gastroenterology (2011) 1.03
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies. Virology (2013) 1.02
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg Med Chem (2005) 1.02
The size-wise nucleus: nuclear volume control in eukaryotes. J Cell Biol (2007) 1.02
Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-alpha. Virology (2004) 1.02
Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry (2004) 1.02
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model. Clin Cancer Res (2004) 1.02
Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol (2006) 1.02
Reconstitution of nuclear import in permeabilized cells. Methods Mol Biol (2009) 1.01
Cross-talk between snurportin1 subdomains. Mol Biol Cell (2005) 1.00
Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc. J Virol (2009) 0.97
Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer. ACS Nano (2009) 0.95
Increased susceptibility to DNA virus infection in mice with a GCN2 mutation. J Virol (2011) 0.95
DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication. J Mol Biol (2011) 0.95
Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics. J Biol Chem (2014) 0.94
Identification of a small molecule inhibitor of importin β mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries. ACS Chem Biol (2010) 0.93
Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses. Curr Opin Virol (2011) 0.93
Repression of classical nuclear export by S-nitrosylation of CRM1. J Cell Sci (2009) 0.93
Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. Virology (2008) 0.92
In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity. Virology (2005) 0.92
NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation. J Biol Chem (2009) 0.91
Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport. Bioorg Med Chem (2010) 0.90
Structural variations in species B adenovirus fibers impact CD46 association. J Virol (2008) 0.90
Guiding plant virus particles to integrin-displaying cells. Nanoscale (2012) 0.90
Synergy of silent and hot spot mutations in importin beta reveals a dynamic mechanism for recognition of a nuclear localization signal. J Biol Chem (2003) 0.89
Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano (2011) 0.89
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy. Cancer Res (2003) 0.88
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial. Antivir Ther (2013) 0.88
Adenovirus infection: taking the back roads to viral entry. Curr Biol (2003) 0.87
An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One (2013) 0.87
Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3. Am J Pathol (2013) 0.87
Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. Laryngoscope (2005) 0.86
Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr. BMC Cell Biol (2009) 0.86
CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol (2005) 0.86
Analysis of nuclear protein import and export in vitro using fluorescent cargoes. Methods Mol Biol (2002) 0.85
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein. Antimicrob Agents Chemother (2013) 0.85
Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation. Cell Microbiol (2010) 0.85
Disulfide-bond formation by a single cysteine mutation in adenovirus protein VI impairs capsid release and membrane lysis. Virology (2012) 0.84
Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes. Mol Ther (2006) 0.84
Herpesvirus hijacks an integrin. Nat Cell Biol (2002) 0.83
Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis. J Cell Biol (2013) 0.83
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors. Cancer Lett (2003) 0.83
Identification of novel integral membrane proteins of the nuclear envelope with potential disease links using subtractive proteomics. Novartis Found Symp (2005) 0.82
MudPIT: A powerful proteomics tool for discovery. Discov Med (2003) 0.82
In vivo transduction of photoreceptors or ciliary body by intravitreal injection of pseudotyped adenoviral vectors. Mol Ther (2003) 0.81
Structural basis of nonenveloped virus cell entry. Adv Protein Chem (2003) 0.81
The structure of the NXF2/NXT1 heterodimeric complex reveals the combined specificity and versatility of the NTF2-like fold. J Mol Biol (2011) 0.80
The identification of an adenovirus receptor by using affinity capture and mass spectrometry. Chembiochem (2004) 0.80
Complement component C1q and anti-hexon antibody mediate adenovirus infection of a CAR-negative cell line. Viral Immunol (2008) 0.77
Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor. Virology (2009) 0.77
Reduction of a 4q35-encoded nuclear envelope protein in muscle differentiation. Biochem Biophys Res Commun (2009) 0.76
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors. Virology (2005) 0.76